Cite
HARVARD Citation
Fresan, D. et al. (n.d.). 5PSQ-012 Are 12 months of treatment with monoclonal antibodies sufficient for migraine attack prevention?. European journal of hospital pharmacy. pp. A121-A122. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fresan, D. et al. (n.d.). 5PSQ-012 Are 12 months of treatment with monoclonal antibodies sufficient for migraine attack prevention?. European journal of hospital pharmacy. pp. A121-A122. [Online].